The National Institute for Health and Care Excellence (NICE) has conditionally approved seven digital technologies to support cardiac rehabilitation for adults with cardiovascular disease (CVD). The final draft guidance states that these platforms can be used in the NHS in England for a 3-year trial period…
MedPage Today) — Planned early-term birth based on risk stratification for preeclampsia reduced the incidence of the complication at term compared with usual care, the randomized PREVENT-PE trial showed. Among over 8,000 women, term preeclampsia…
MedPage Today) — The American College of Cardiology (ACC) officially backed front-of-package (FOP) nutrition labeling as the expected launch of the public health tool by federal officials draws closer. “FOP labeling provides a pragmatic strategy…
This disease can become life-threatening without proper intervention…
🛡️ Verifying that you are not a bot ⏳ Verifying your browser… âś“ Verification Complete This page will redirect in a moment…
MedPage Today) — You passed medical training, now see if you can pass our weekly quiz…
MedPage Today) — A multicomponent intervention in Malawi and Uganda reduced the risk of maternal infection and sepsis compared to usual care, a cluster-randomized trial found. The primary outcome — a composite of infection-related maternal…
MedPage Today) — HOUSTON — A culturally tailored intervention that included dietary tips and other recommendations helped modestly reduce interdialytic weight gain in Hispanic and Latino individuals with hemodialysis-dependent kidney failure…
In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events…
Credit: Pixabay/CC0 Public Domain Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented today at the American Heart Association Scientific Sessions